Business Context and Reporting Period
Company: Actinium Pharmaceuticals, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: September 28, 2016 (Event Date: September 29, 2016)
Context: The Company entered into a material definitive agreement for a public offering of common stock.
Key Financial Metrics and Transaction Details
- Offering Structure: Public offering of 8,000,000 shares of common stock (Firm Shares) at $1.25 per share.
- Over-Allotment Option: Underwriters granted a 30-day option to purchase up to 1,200,000 additional shares (Option Shares).
- Expected Net Proceeds:
- Without over-allotment: Approximately $9,255,000.
- With full over-allotment: Approximately $10,665,000.
- Underwriter: H.C. Wainwright & Co. as representative.
- Expected Closing Date: October 4, 2016, subject to customary conditions.
Note: This filing does not provide historical revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses solely on the capital raise transaction.
Material Changes and Agreements
The primary material change is the execution of the Underwriting Agreement dated September 29, 2016. Key terms include:
- Lock-Up Period: The Company, its directors, and officers agreed not to sell or dispose of any securities held by them for 90 days following the date of the final prospectus supplement, without the Representative's written consent.
- Registration Basis: The offering is made pursuant to an effective Form S-3 registration statement filed in March 2014.
Outlook, Risks, and Management Commentary
- Management Commentary: The Company issued press releases on September 28 and September 29, 2016, announcing the intent and pricing of the offering. These are incorporated by reference but not deemed "filed" under the Exchange Act.
- Risks and Contingencies: The closing of the offering is subject to the satisfaction of customary closing conditions. The Underwriting Agreement contains customary representations, warranties, indemnification obligations, and termination provisions.
- Legal Opinion: A legal opinion regarding the Common Stock being offered was provided by The Matt Law Firm, PLLC.
Investor Verification Checklist
- Verify the final closing date of the offering (expected October 4, 2016) and whether customary conditions were met.
- Confirm whether the underwriters exercised the 30-day over-allotment option for the 1,200,000 Option Shares.
- Review the final prospectus supplement for the exact net proceeds after deducting all underwriting discounts and offering expenses.
- Check subsequent filings for any changes in the Company's capitalization or use of proceeds.